OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Type 2 immunity is maintained during cancer-associated adipose tissue wasting
Patrick J. Lenehan, Assunta Cirella, Amiko M. Uchida, et al.
Immunotherapy Advances (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 14
Patrick J. Lenehan, Assunta Cirella, Amiko M. Uchida, et al.
Immunotherapy Advances (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Transforming Growth Factor-β Blockade in Pancreatic Cancer Enhances Sensitivity to Combination Chemotherapy
Qiang Li, Megan T. Hoffman, Lestat R. Ali, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 874-890.e10
Open Access | Times Cited: 37
Qiang Li, Megan T. Hoffman, Lestat R. Ali, et al.
Gastroenterology (2023) Vol. 165, Iss. 4, pp. 874-890.e10
Open Access | Times Cited: 37
Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
Bahar Zehra Camurdanoglu Weber, Dilşad H. Arabacı, Serkan Kır
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Bahar Zehra Camurdanoglu Weber, Dilşad H. Arabacı, Serkan Kır
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 29
Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back
Viviane Schmidt, Andrew E. Hogan, Padraic G. Fallon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Viviane Schmidt, Andrew E. Hogan, Padraic G. Fallon, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 25
Cytokines in cancer
Courtney T.S. Kureshi, Stephanie K. Dougan
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 15-35
Closed Access | Times Cited: 5
Courtney T.S. Kureshi, Stephanie K. Dougan
Cancer Cell (2024) Vol. 43, Iss. 1, pp. 15-35
Closed Access | Times Cited: 5
Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
Michael J. Walsh, Lestat R. Ali, Patrick J. Lenehan, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 10
Michael J. Walsh, Lestat R. Ali, Patrick J. Lenehan, et al.
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 10
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer
Lestat R. Ali, Patrick J. Lenehan, Victoire Cardot‐Ruffino, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 542-553
Open Access | Times Cited: 10
Lestat R. Ali, Patrick J. Lenehan, Victoire Cardot‐Ruffino, et al.
Clinical Cancer Research (2023) Vol. 30, Iss. 3, pp. 542-553
Open Access | Times Cited: 10
Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer
Courtney T. Stump, Kevin Roehle, Nataly Manjarrez‐Orduño, et al.
Open Biology (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 20
Courtney T. Stump, Kevin Roehle, Nataly Manjarrez‐Orduño, et al.
Open Biology (2021) Vol. 11, Iss. 11
Open Access | Times Cited: 20
cIAP1/2 Antagonism Induces Antigen-Specific T Cell–Dependent Immunity
Katherine S. Ventre, Kevin Roehle, Elisa Bello, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 7, pp. 991-1003
Open Access | Times Cited: 7
Katherine S. Ventre, Kevin Roehle, Elisa Bello, et al.
The Journal of Immunology (2023) Vol. 210, Iss. 7, pp. 991-1003
Open Access | Times Cited: 7
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans
Victoire Cardot‐Ruffino, Naïma Böllenrücher, Luisa Delius, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006589-e006589
Open Access | Times Cited: 7
Victoire Cardot‐Ruffino, Naïma Böllenrücher, Luisa Delius, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006589-e006589
Open Access | Times Cited: 7
Human differentiated eosinophils release IL-13 in response to IL-33 stimulation
Amiko M. Uchida, Gabrielle Ro, Qiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Amiko M. Uchida, Gabrielle Ro, Qiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
MARCKS is a New Prognostic Biomarker in Hepatocellular Carcinoma
Haoran Lu, Rou Zhao, Qianqian Qin, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1603-1619
Open Access | Times Cited: 2
Haoran Lu, Rou Zhao, Qianqian Qin, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 1603-1619
Open Access | Times Cited: 2
Harnessing immunometabolism for cardiovascular health and cancer therapy
Angela Markovska, Henk S. Schipper, Marianne Boes
Immunotherapy Advances (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 4
Angela Markovska, Henk S. Schipper, Marianne Boes
Immunotherapy Advances (2021) Vol. 1, Iss. 1
Open Access | Times Cited: 4
Clinical significance of peripheral blood-derived inflammation markers combined with serum eotaxin-2 in human colorectal cancer
Mingfu Tong, Huimin Liu, Huan Xu, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 3, pp. 1774-1790
Closed Access | Times Cited: 1
Mingfu Tong, Huimin Liu, Huan Xu, et al.
Biotechnology and Genetic Engineering Reviews (2023) Vol. 40, Iss. 3, pp. 1774-1790
Closed Access | Times Cited: 1
Editorial: Immunology of cachexia
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access
Vijay Kumar, John H. Stewart
Frontiers in Immunology (2023) Vol. 14
Open Access
